Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population

BMC Public Health

De-Hong Cai²  Hui Chen¹  Xiao-Yun Ke¹  Rui Yang²  Jia Sun²  Rong-Ping Chen²  Ru-Yi Zhang²  Jiao Wang² 

[1] Department of Ophthalmology, Zhujiang Hospital, Southern Medical University, 253# industry road, Guangzhou 510282, China;Department of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, China

关键词: Risk factors;    Prevalence;    Diabetic retinopathy;    People with high risk for diabetes;    Finnish diabetes risk score;   

Others  :  1162049
DOI  :  10.1186/1471-2458-13-633

 received in 2012-09-05, accepted in 2013-07-02,  发布年份 2013

【 摘 要 】

Background

Lifestyle plays an important role in the development of diabetic retinopathy. The lifestyle in Guangzhou is different from other cities in China as the Cantonese prefer eating rice porridge, but not spicy foods. The objectives of this study were to investigate the prevalence and determinants of diabetic retinopathy in a high-risk population of Guangzhou.

Methods

Subjects (619 totals) aged over 45 years old, without known diabetes were recruited from five randomly selected Guangzhou communities in 2009–2010. All participants were invited to complete the Finnish Diabetes Risk Score (FINDRISC) questionnaire. Subjects with FINDRISC score ≥ 9 were included in the study, and underwent an investigation of demographic data, a standardized physical examination, ocular fundus examination, and laboratory analyses. The minimum criterion for diagnosis of diabetic retinopathy was the presence of at least one microaneurysm.

Results

Of 619 subjects, 208 eligible subjects (122 women) with FINDRISC score ≥ 9 were included in the study. The mean age was 69.2 ± 8.5 years. Diabetic retinopathy was detected in 31 subjects, and the prevalence of diabetic retinopathy in subjects with high risk for diabetes was 14.9%. In binary logistic regression analysis, risk factors associated with diabetic retinopathy were history of impaired glucose regulation [odds ratio (OR), 7.194; 95% confidence interval (CI): 1.083, 47.810], higher hemoglobin A1c (HbA1c; OR, 2.912; 95% CI: 1.009, 8.402), higher two-hour postprandial plasma glucose level (OR, 1.014; 95% CI: 1.003, 1.025), and presence of microalbuminuria (OR, 5.387; 95% CI: 1.255, 23.129).

Conclusions

Diabetic retinopathy was prevalent in a high-risk Chinese population from Guangzhou. Histories of impaired glucose regulation and microalbuminuria were strong risk factors for diabetic retinopathy.

【 授权许可】

   
2013 Wang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Kempen JH, O’Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, et al.: Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 2004, 122(4):552-563.
• [2]Cheung N, Wong TY: Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res 2008, 27(2):161-176.
• [3]Liew G, Wong TY, Mitchell P, Cheung N, Wang JJ: Retinopathy predicts coronary heart disease mortality. Heart 2008, 95(5):391-394.
• [4]Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al.: Prevalence of diabetes among Men and women in china. N Engl J Med 2010, 362(12):1090-1101.
• [5]Pang C, Jia L, Jiang S, Liu W, Hou X, Zuo Y, et al.: Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and pre-diabetic subjects: Shanghai diabetic complications study. Diab/Metab Res Reviews 2012, 28(3):276-283.
• [6]Lee KM, Sum WM: Prevalence of diabetic retinopathy in patients with recently diagnosed diabetes mellitus. Clin Exp Optometry 2011, 94(4):371-375.
• [7]He YH, Jiang GX, Yang Y, Huang HE, Li R, Li XY, et al.: Obesity and its associations with hypertension and type 2 diabetes among Chinese adults age 40 years and over. Nutrition 2009, 25(11–12):1143-1149.
• [8]Chaiyasit K, Khovidhunkit W, Wittayalertpanya S: Pharmacokinetic and the effect of capsaicin in Capsicum frutescens on decreasing plasma glucose level. J Med Assoc Thai 2009, 92(1):108-113.
• [9]Kang JH, Kim C, Han IS, Kawada T, Yu R: Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages. FEBS Lett 2007, 581(23):4389-4396.
• [10]Winkler G, Hídvégi T, Vándorfi G, Balogh S, Jermendy G: Prevalence of undiagnosed abnormal glucose tolerance in adult patients cared for by general practitioners in Hungary. Results of a risk-stratified screening based on FINDRISC questionnaire. Med Sci Monit 2013, 19:67-72.
• [11]Bergmann A, Li J, Wang L, Schulze J, Bornstein SR, Schwarz PE: A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population. Horm Metab Res 2007, 39(9):677-682.
• [12]Costa B, Barrio F, Piñol JL, Cabré JJ, Mundet X, Sagarra R, et al.: Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish diabetes risk score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy. BMC Med 2013, 11(1):45. BioMed Central Full Text
• [13]Garcia-Alcala H, Soto Vega E, Genestier Tamborero CN, Salinas Palma JL, Hirales Tamez O: Frequency of diabetes, impaired fasting glucose, and glucose intolerance in high-risk groups identified by a FINDRISC survey in Puebla City, Mexico. Diab Metab Syndrome Obes Targets Therapy 2012, 5:403-406.
• [14]Hellgren MI, Petzold M, Björkelund C, Wedel H, Jansson PA, Lindblad U: Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study. Diab Med 2012, 29(12):1501-1505.
• [15]Makrilakis K, Liatis S, Grammatikou S, Perrea D, Katsilambros N: Implementation and effectiveness of the first community lifestyle intervention programme to prevent Type 2 diabetes in Greece. The DE-PLAN study. Diabet Med 2010, 27(4):459-465.
• [16]Makrilakis K, Liatis S, Grammatikou S, Perrea D, Stathi C, Tsiligros P, et al.: Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece. Diabetes Metab 2011, 37(2):144-151.
• [17]Saaristo T, Moilanen L, Korpi-Hyövälti E, Vanhala M, Saltevo J, Niskanen L, et al.: Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish national diabetes prevention program (FIN-D2D). Diabetes Care 2010, 33(10):2146-2151.
• [18]Tankova T, Chakarova N, Atanassova I, Dakovska L: Evaluation of the Finnish diabetes risk score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes. Diabetes Res Clin Pract 2011, 92(1):46-52.
• [19]Wang J, Stancáková A, Kuusisto J, Laakso M: Identification of undiagnosed type 2 diabetic individuals by the finnish diabetes risk score and biochemical and genetic markers: a population-based study of 7232 Finnish men. J Clin Endocrinol Metab 2010, 95(8):3858-3862.
• [20]Lindström J, Tuomilehto J: The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003, 26(3):725-731.
• [21]Franciosi M, De Berardis G, Rossi MC, Sacco M, Belfiglio M, Pellegrini F, et al.: Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study. Diabetes Care 2005, 28(5):1187-1194.
• [22]Wong TY, Cheung N, Tay WT, Wang JJ, Aung T, Saw SM, et al.: Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology 2008, 115(11):1869-1875.
• [23]Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, et al.: Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003, 110(9):1677-1682.
• [24]Department of Noncommunicable Disease Surveillance: Definition, diagnosis and classif ication of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999.
• [25]Guidelines subcommittee: 1999 World health organization-international society of hypertension guidelines for the management of hypertension. J Hypertens 1999, 17(2):151-183.
• [26]Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V: Prevalence of diabetic retinopathy in urban India: the Chennai urban rural epidemiology study (CURES) eye study, I. Invest Ophthalmol Vis Sci 2005, J46(7):2328-2333.
• [27]Tapp RJ, Shaw JE, Harper CA, de Courten MP, Balkau B, McCarty DJ, et al.: The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 2003, 26(6):1731-1737.
• [28]Kim JH, Kwon HS, Park YM, Lee JH, Kim MS, Yoon KH, et al.: Prevalence and associated factors of diabetic retinopathy in rural Korea: the chungju metabolic disease cohort study. J Korean Med Sci 2011, 26(8):1068.
• [29]Mohamed Q, Gillies MC, Wong TY: Management of diabetic retinopathy: a systematic review. JAMA 2007, 298(8):902-916.
• [30]Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, et al.: Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA 2010, 304(6):649-656.
• [31]Park CY, Park SE, Bae JC, Kim WJ, Park SW, Ha MM, et al.: Prevalence of and risk factors for diabetic retinopathy in Koreans with type II diabetes: baseline characteristics of Seoul metropolitan city-diabetes prevention program (SMC-DPP) participants. Brit J Ophthalmol 2011, 96(2):151-155.
• [32]Xu J, Wei WB, Yuan MX, Yuan SY, Wan G, Zheng YY, et al.: Prevalence and risk factors for diabetic retinopathy: the Beijing communities diabetes study 6. Retina 2012, 32(2):322-329.
• [33]Chen H, Zheng Z, Huang Y, Guo K, Lu J, Zhang L, et al.: A microalbuminuria threshold to predict the risk for the development of diabetic retinopathy in type 2 diabetes mellitus patients. PLoS One 2012, 7(5):e36718.
• [34]Cruickshanks KJ, Ritter LL, Klein R, Moss SE: The association of microalbuminuria with diabetic retinopathy. The Wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology 1993, 100(6):862-867.
• [35]Tam TK, Lau CM, Tsang LC, Ng KK, Ho KS, Lai TC: Epidemiological study of diabetic retinopathy in a primary care setting in Hong Kong. Hong Kong Med J 2005, 11(6):438-444.
• [36]Wang FH, Liang YB, Peng XY, Wang JJ, Zhang F, Wei WB, et al.: Risk factors for diabetic retinopathy in a rural Chinese population with type 2 diabetes: the Handan Eye Study. Acta Ophthalmol 2011, 89(4):e336-e343.
• [37]Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR: Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia 2006, 49(8):1761-1769.
• [38]Huang OS, Lamoureux EL, Tay WT, Tai ES, Wang JJ, Wong TY: Glycemic and blood pressure control in an asian malay population with diabetes and diabetic retinopathy. Arch Ophthalmol 2010, 128(9):1185-1190.
• [39]Klein R, Klein BE, Moss SE: Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 1996, 124(1 Pt 2):90-96.
• [40]Grosso A, Cheung N, Veglio F, Wong TY: Similarities and differences in early retinal phenotypes in hypertension and diabetes. J Hypertens 2011, 29(9):1667-1675.